Busca un médico

Subha Hanif, M.D.

  1. Physiatrist

Subha Hanif, M.D., is a Senior Associate Consultant in the Department of Physical Medicine and Rehabilitation at Mayo Clinic Rochester. She specializes in Cancer Rehabilitation with particular expertise in gynecologic oncology, pelvic floor dysfunction, lymphedema, cancer-related pain, chemotherapy-induced neuropathies, head and neck cancer related impairments, and survivorship-focused functional care.

Dr. Hanif is committed to building comprehensive, evidence-based cancer rehabilitation programs that support patients across the treatment continuum — from diagnosis and prehabilitation through acute care, recovery, and long-term survivorship. She also performs specialized interventional procedures to address cancer-related pain and functional impairments.

Her clinical practice centers on restoring function, optimizing quality of life, and ensuring each patient receives coordinated, compassionate, and expert multidisciplinary care for a wide range of musculoskeletal, neurologic, and cognitive impairments arising from cancer or its treatments.

  1. Axial spondyloarthritis
  2. Back pain
  3. Balance problem
  4. Brain cancer
  5. Breast cancer
  6. Breast cancer-related lymphedema
  7. Cachexia
  8. Cancer
  9. Cancer-related fatigue
  10. Cancer-related pain
  11. Cancer-related weakness
  12. Cervical cancer
  13. Delirium
  14. Demyelinating neuropathy
  15. Endometrial cancer
  16. Functional limitation
  17. Functional movement disorder
  18. Functional neurologic disorder
  19. Gait unsteadiness
  20. Head and neck cancer
  21. Lymphedema
  22. Muscle atrophy
  23. Muscle weakness
  24. Myalgic encephalomyelitis/chronic fatigue syndrome
  25. Neck pain
  26. Neuromuscular disorder
  27. Neuropathy
  28. Ovarian cancer
  29. Pelvic floor dysfunction
  30. Pelvic floor pain disorder
  31. Spasticity
  32. Uterine carcinoma
  1. Botox injection
  2. Cancer rehabilitation
  3. Inpatient rehabilitation
  4. Musculoskeletal exam
  5. Outpatient clinical consultation
  6. Rehabilitation therapy
  7. Spasticity injection
  8. Spasticity therapy
  • Gynecologic Oncology Rehabilitation:
  • Pelvic floor dysfunction (post-surgical, radiation-related, chemotherapy-related)
  • Pelvic radiation fibrosis and chronic pelvic pain
  • Pelvic floor prehabilitation prior to major oncologic surgery
  • Postoperative mobility, core activation, and return-to-function strategies
  • Lymphedema & Vascular-Lymphatic Disorders:
  • Cancer-related lymphedema (lower extremity, genital, truncal, upper extremity)
  • Complex lymphatic and edema syndromes related to gynecologic, breast, and pelvic cancers
  • Neuromuscular & Neuropathy Syndromes:
  • Chemotherapy-induced peripheral neuropathy
  • Myopathy, deconditioning, and treatment-related weakness
  • Gait, balance, and fall-risk impairments
  • Radiation-Related Morbidity:
  • Pelvic radiation fibrosis
  • Shoulder dysfunction, cranial nerve deficits, and fibrosis after head and neck radiation
  • Trismus and jaw mobility limitations
  • Cancer-Related Pain Syndromes:
  • Post-Mastectomy Pain Syndrome (PMPS)
  • Myofascial pain, scar pain, post-surgical soft-tissue pain
  • Musculoskeletal pain during chemotherapy and endocrine therapy
  • Neuropathic and radicular pain related to cancer treatments
  • Head & Neck Cancer Functional Impairments:
  • Trismus and jaw dysfunction
  • Dysphagia-related cervical and shoulder impairments
  • Neck fibrosis and post-radiation pain syndromes
  • Survivorship & Functional Medicine:
  • Cancer-related fatigue
  • Exercise prescription during and after oncology treatment
  • Return-to-work and return-to-life planning
  • Long-term survivorship functional care
  • Procedural & Interventional Cancer Rehabilitation:
  • Ultrasound-guided joint injections
  • Trigger point and myofascial injections
  • Nerve blocks for cancer-related neuropathic pain
  • Botulinum toxin injections for radiation fibrosis, spasticity, and PMPS-related pain patterns
  • Special Populations & Complex Care:
  • Prehabilitation for surgical and systemic oncology treatments
  • Functional optimization for high-risk or frail oncology patients
  • Integrating PM&R within multidisciplinary oncology pathways